| (210) | Number of the EPO application | 22714958 |
| (220) | Filing date of the EPO application | 2022.03.02 |
| (80) | EPO patent specification publication (B) | EPB nr. 35/2025, 2025.08.27 |
| (110) | EPO patent number | 4301770 |
| (11) | Number of the document | MD 4301770 T2 |
| (21) | Number of the application | e 2024 0053 |
| (71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
| (72) | Name(s) of inventor(s), code of the country | ABRAHAM Milata Mary, US;
BRIERE Daniel Anthony, US;
GUO Lili, US;
KEYSER Samantha Grace Lyons, US;
LEE John, US;
QU Hongchang, US; |
| (73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
| (54) | Title of the invention | Long-acting amylin receptor agonists and uses thereof |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 14/605 (2006.01.01); A61K 38/00 (2006.01.01); A61K 38/17 (2006.01.01); A61P 3/10 (2006.01.01); A61K 38/22 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2024.01.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2026.01.31 |
| (30) | Priority | 202163155894 P, 2021.03.03, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2022/018434, 2022.03.02 |
| (87) | International publication | WO 2022/187305, 2022.09.09 |